Wordt geladen...
Endometrial Profile of Tamoxifen and Low-dose Estradiol Combination Therapy
PURPOSE: Combination estrogen+progestin therapy has been associated with increased breast cancer risk in postmenopausal women. Selective estrogen receptor modulators (SERMs) are potential alternatives to progestins, although endometrial safety of estrogen+SERM co-therapies is not known. The goal of...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2818660/ https://ncbi.nlm.nih.gov/pubmed/20103679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1541 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|